- Fractyl Health to Present at Piper Sandler 2nd Annual Virtual Obesity Day
- Fractyl Health Announces Advancement in Weight Maintenance Pipeline and Business Updates
- Fractyl Health Presents New Preclinical Data on Sustained Weight Maintenance and Improved Body Composition from its Rejuva® Single-Administration GLP-1 Pancreatic Gene Therapy in President’s Select Oral Presentation at the American Diabetes Association’s 84th Scientific Sessions
- Fractyl Health to Present New Preclinical Obesity Data from Rejuva® Platform at the American Diabetes Association’s 84th Scientific Sessions
- Fractyl Health Presents Compelling Preclinical Data from Single-Administration GLP-1 Pancreatic Gene Therapy Rejuva® at Digestive Disease Week 2024
- Fractyl Health Reports First Quarter 2024 Financial Results and Provides Business Updates
- Fractyl Health Presents Clinical Update on Revita® German Real-World Registry for Patients With Advanced Type 2 Diabetes (T2D)
- Fractyl Health to Present at BofA Securities 2024 Health Care Conference
- Fractyl Health to Report First Quarter 2024 Financial Results and Provide Business Updates on May 13, 2024
- Fractyl Health Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference and the German Diabetes Association (DDG) Annual Meeting
More ▼
Key statistics
On Wednesday, Fractyl Health Inc (GUTS:NMQ) closed at 4.47, 12.31% above the 52 week low of 3.98 set on Jun 24, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.49 |
---|---|
High | 4.70 |
Low | 4.32 |
Bid | 4.32 |
Offer | 4.47 |
Previous close | 4.44 |
Average volume | 374.46k |
---|---|
Shares outstanding | 47.90m |
Free float | 45.81m |
P/E (TTM) | -- |
Market cap | 212.66m USD |
EPS (TTM) | -1.73 USD |
Data delayed at least 15 minutes, as of Jul 03 2024 18:00 BST.
More ▼